Dr. Amanda Hope Champlain, MD

Dr. Champlain practices at Revival Dermatology in Dallas, Texas.

Dr. Champlain's NPI, 1003180993, was assigned on February 24, 2012. Dr. Champlain graduated from University of Oklahoma College of Medicine in 2011. Dr. Champlain holds Texas license S1782.

Dr. Champlain's primary practice is Revival Dermatology, at 8201 Preston Rd Suite 440 Suite 440, Dallas, TX 75225-6209. The practice phone is (214) 675-3227.

Dr. Champlain's primary practice is Revival Dermatology in Dallas, Texas. The medical group on file is Revival Dermatology. Dmand AI also links Dr. Champlain to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Champlain practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Champlain's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Champlain is board certified in dermatology by the American Board of Dermatology. Dr. Champlain is licensed in Texas.

CMS data shows 116 Medicare services from Dr. Champlain across 5 procedure codes in 2024, for 61 Medicare patients. Medicare paid $7,282 for them. Every service was in an office.

CMS counts 61 Medicare patients who saw Dr. Champlain in 2024. The largest group is 65 to 74, with 44 patients. 64% of them have high cholesterol, and 62% have high blood pressure. Their average risk score is 0.70, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Champlain's median patient age at 42, with 69% women.

In 2024, Dr. Champlain wrote 91 Medicare Part D claims for 42 patients. 92% of them were for generic drugs. CMS names the drug for 28 of them, across 2 drugs with 11 or more claims each, at $860 in total drug cost. In 2023, CMS named 29 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Champlain for performance year 2024, reported as part of a group. Dr. Champlain accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 112 procedures of removal of skin lesions by Dr. Champlain, more than 76% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Champlain, published from 2015 to 2022. The most frequent topics are Skin, Skin Aging and Skin Neoplasms. Dr. Champlain has published most often in Dermatol Surg. Dr. Champlain's most frequent co-authors are Rebecca Clare Tung, MD, Richard Rox Anderson, MD and Lauren Moy, MD.

CMS Open Payments shows 494 general payments to Dr. Champlain from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $3,014.

Dr. Champlain graduated from University of Oklahoma College of Medicine in 2011.